IABP-SHOCK II
2012
Intra-Aortic Balloon Pump in Cardiogenic Shock
In 600 patients with MI-related cardiogenic shock undergoing revascularisation, intra-aortic balloon counterpulsation did not reduce 30-day mortality versus no IABP.
Result
Efficacy: 30-day all-cause mortalityRR 0.96 · P = 0.69
Below 1 favours intra-aortic balloon counterpulsation, above 1 favours no IABP.
- Absolute difference
- 1.6 points
The absolute difference is derived from the event rates.
Also reported: Persistent null at 1, 6 and 12 y.
- Subtopic
- Mechanical support
- Design
- Multicentre RCT, Germany
- Relevance
- Practice-defining: a trial the field needs to know.
- Source
- Thiele H, et al. N Engl J Med. 2012;367(14):1287-1296.doi 10.1056/NEJMoa1208410
Discussion & critique
Retired routine IABP; guidelines downgraded to Class IIIa.